Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology _ Genomics, Genetic Testing, Gene & DNA Sequencing, NGS (Next Generation Sequencing) Companies

IntegenX (Formerly, Microchip Biotechnologies)

Parents

*Portfolio Companies: In-Q-Tel
Architects: Biotechnology _ Genomics, Genetic Testing, Gene & DNA Sequencing, NGS (Next Generation Sequencing) Companies
Architects: Biotechnology (Laboratory Equipment, Testing, Tools, Reagents & Test Kit Companies)
Architects: Biotechnology_Genomics, Multiomics
Architects: Laboratory Equipment, Information Systems & Services, Biotechnology, Biology, BioChemistry and Biomanufacturing, Specimens, & Cell Manufacturing, Good Manufacturing Practice (GMP) Software, Supplies & Blood Systems
Finance & Acquisitions: In-Q-Tel
Venture Capital: Series C

developer of rapid human DNA identification technology and DNA sequencing library preparation systems
GenVault Corporation
GenVault head raised $46 million in venture funding from Cross Creek Capital, Domain Associates, Greenspring Associates, and QuestMark Partners
IntegenX Adds $16M, Buys GenVault (2011)
IntegenX has now raised $38.2 million in total from Domain Associates, In-Q-Tel, Rona Syndicates, Samsung Ventures America, and Western Technology Investment (2011)
IntegenX makes automated sample preparation systems for genetics laboratories, and GenVault produces bio-sample storage systems that do not depend on refrigeration
IntegenX Raises $40 Million Series C Financing to Speed (2011)
Microscale On Chip Valve nanofluidic platform
Pleasanton, California
Raised $15.6 million in new capital in a round led by existing investor Domain Associates (2011)
sample-to-answer products for DNA-based human identity testing and forensics, next generation sequencing, biodefense, and molecular diagnostics applications.
Series A, $4.5m
The RapidHIT 200 will allow DNA analysis at the point of collection, such as an arrest or detention, setting a new standard in the usage of DNA profiles as an actionable biometric.